Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO Preceptorship on Immuno-Oncology Singapore November 2018

26 - 27 Nov 2018

Republic of Singapore

ESMO Preceptorship on Immuno-Oncology
Leaning objectives
  • To understand the basics of tumour immunology
  • To learn about the essentials of immunotherapies and their present indication in cancer treatment
  • To learn about the status of development and clinical experience of immunotherapy in different tumour types

Presentations of the ESMO Preceptorship on Immuno-Oncology Singapore November 2018 are available to ESMO members according to the presenters' agreement to release them. The use of these presentations is for personal educational purposes only. ESMO thanks the authors for their generosity. Meeting programme | Find out about future ESMO Preceptorship Courses

Hide
Filter by:

There are 24 resources available

Welcome

Presenter: J. B.A.G. Haanen, NL; R. A. Soo, SG

Session: Welcome

Resources:

Slides

Melanoma Advanced and Adjuvant

Presenter: J. B.A.G. Haanen, NL

Session: Session 2 Recent Advances with ICPI: Results in Approved/Unapproved Indication - part 1

Resources:

Slides

Non-Small-Cell Lung Cancer

Presenter: R. A. Soo, SG

Session: Session 2 Recent Advances with ICPI: Results in Approved/Unapproved Indication - part 1

Resources:

Slides

Assessment of Efficacy

Presenter: K. J. O’Byrne, AU

Session: Session 3 Clinical Issues - part 1

Resources:

Slides

Biomarkers: PD-L1

Presenter: T.-Y. Chou, TW

Session: Session 3 Clinical Issues - part 1

Resources:

Slides

Oesophageal and Gastric Cancer

Presenter: Y.-J. Bang, KR

Session: Session 4 Recent Advances with ICPI: Results in Approved/Unapproved Indication - part 2

Resources:

Slides

Hepatocellular Carcinoma (HCC)

Presenter: C. E. Chee, SG

Session: Session 4 Recent Advances with ICPI: Results in Approved/Unapproved Indication - part 2

Resources:

Slides

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings